Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors.

Autor: Genc, Selin1 (AUTHOR) selin.genc@saglik.gov.tr, Evren, Bahri2 (AUTHOR) bahri.evren@inonu.edu.tr, Yigit, Onur Selcuk3 (AUTHOR) onurselcuk.yigit@saglik.gov.tr, Sahin, Ibrahim4 (AUTHOR) ibrahimsahin@memorial.com.tr, Dayanan, Ramazan5 (AUTHOR) ramazan.dayanan@saglik.gov.tr, Klisic, Aleksandra6,7 (AUTHOR) aleksandranklisic@gmail.com, Erturk, Ayse8 (AUTHOR) ayse.erturk@erdogan.edu.tr, Mercantepe, Filiz9 (AUTHOR) ayse.erturk@erdogan.edu.tr
Zdroj: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1553. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje